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Abstract.  The involvement of integrins  in mediating 
interaction of cells to well-characterized proteolytic 
fragments (P1,  E3, and  E8) of laminin  was assessed by 
antibody blocking studies.  Cell adhesion to fragment 
P1 was affected by mAbs against the integrin/51  and 
/53 subunits and furthermore could be prevented com- 
pletely by a  synthetic peptide containing the Arg-Gly- 
Asp sequence.  Because the 153 antibody-sensitive cell 
lines expressed the vitronectin  receptor (otv/53) at high 
levels, the involvement of this  receptor in cell adhe- 
sion to P1  is strongly suggested. Integrin-mediated  cell 
adhesion to E3  is of low affinity and was inhibited by 
antibodies against the integrin/51  subunit.  In contrast, 
adhesion of some cell types to E3  was not or only 
partially  sensitive to inhibition by anti-integrin  subunit 
antibodies.  Cell adhesion to E8 was blocked com- 
pleted by integrin ct6 or/51  antibodies.  The t~6-specific 
antibody did not inhibit cell adhesion to E3  or P1. 
Furthermore,  the antibody only blocked adhesion to 
laminin  of those cells that adhered exclusively to the 
E8 fragment.  In addition,  expression of a6fll  was 
closely correlated with the ability of cells to bind to 
the E8 fragment of laminin.  These results indicate that 
the o~6/51 integrin  is a  specific receptor for the E8 
fragment of laminin.  Many cell types expressed, in- 
stead of or in addition to a6/51  the recently described 
integrin ot6f14. Although the ligand of 0t6/54 was not 
identified,  it must be different from that of c~6/51, be- 
cause cells that express ~6/54,  but not c~6/51, do not 
adhere to E8,  and cell adhesion to E8 was specifically 
blocked by/51 specific antibodies.  In conclusion, the 
data indicate that distinct integrin  receptors belonging 
to the/51  or/53  subfamily are involved in adhesion of 
cells to the various laminin  fragments.  Adhesion to E3 
may also be brought about by other receptor mole- 
cules, possibly proteoglycans, not belonging to the 
integrin  family. 
AMININ is a large (850 kD) adhesive glycoprotein found 
exclusively  in basement membranes and consists  of 
three polypeptide chains, A (400 kD), B1 (225 kD), 
and B2 (205 kD) (Chung  et al.,  1979; Timpl et al.,  1979; 
Sasaki et al.,  1988; Timpl,  1989). The subunits  are linked 
through  disulfide  bonds into a unique cross-shaped struc- 
ture. A wide range of cellular and consequently tissue func- 
tions, e.g., spreading,  locomotion, proliferation,  and differ- 
entiation of cells (Martin and Timpl,  1987; Timpl,  1989) are 
thought  to be dependent on interactions  of these cells with 
laminin.  Laminin  also induces and promotes the outgrowth 
of neurites  (Baron-van  Evercooren et al.,  1982).  Studies 
with proteolytic fragments of laminin  have identified  frag- 
ment E8, the terminal half of the long arm of laminin,  as the 
site with which neuronal  cells interact  (Edgar et al.,  1984). 
Subsequent studies  indicated  that this fragment also serves 
as an attachment site for many nonneuronal  cells (Aumailley 
et al.,  1987; Goodman et al.,  1987). Two other proteolytic 
fragments  which have cell attachment  activity are fragment 
El-4  (Goodman et al.,  1987),  corresponding to the three 
short arms of laminin,  and  fragment P1  (or El),  which is 
identical to El-4 except that it lacks a substantial  portion of 
the structures at the ends of the short arms.  The P1 cell- 
binding  site has recently been shown to be cryptic in lami- 
nin,  and  to require proteolytic activation  for its exposure 
(Nurcombe et al., 1989). Still another fragment E3 has been 
identified as a major heparin binding domain on laminin (Ott 
et al., 1982) but has so far not been found to be a good cell 
adhesion  substrate (Goodman et al.,  1987). 
Cell adhesion to laminin and its fragments is mediated by 
specific cell surface receptors. A family of adhesion  recep- 
tors for extracellular  matrix proteins has been identified on 
a variety of cells (Hynes, 1987; Ruoslahti and Pierschbacher, 
1987). These receptors, referred to as integrins,  are trans- 
membrane protein complexes consisting of noncovalently as- 
sociated c~ and fl subunits. At present, 11 different ct subunits 
©  The Rockefeller University Press, 0021-9525/90/06/2145/11  $2.00 
The Journal of Cell Biology, Volume 110, June 1990 2145-2155  2145 and six different B subunits have been identified. The/31,/~2, 
and B3 subunits can associate with multiple distinct a  sub- 
units and define three integrin subfamilies: the VLA protein 
family (Hemler et al.,  1987;  Hemler,  1988), the Leu-Cam 
family (Springer et al.,  1987), and the cytoadhesins (Gins- 
berg et al., 1988), respectively. The VLA subfamily of inte- 
grins includes receptors for fibronectin, laminin, and colla- 
gens.  Members of this  family contain one of at least six 
distinct a  subunits, noncovalently associated with a common 
B1  subunit  (Hemler et al.,  1987;  Hemler,  1988;  Hemler 
et al.,  1988). Four of these VLA proteins, VLA-1  (criB1), 
VLA-2  (ct2B1),  VLA-3  (ct3B1),  and  VLA-6  (ot6B1), have 
been shown to function as receptors for laminin (Wayner and 
Carter, 1987; Gehlsen et al.,  1988; Ignatius and Reichardt, 
1988;  Sonnenberg et al.,  1988a;  Languino et al.,  1989; 
Turner et al.,  1989;  Elices and Hemler, 1989). An integrin 
isolated by laminin affinity chromatography from melanoma 
cells, which has an a  subunit distinct from the six known a 
subunits,  but an identical VLA B1  subunit,  may represent 
just another member of this VLA protein family involved in 
cell adhesion to laminin (Kramer et al.,  1989). In addition 
to functioning as laminin receptors, VLA-1 is a receptor for 
collagen (Kramer and Marks, 1989; Turner et al., 1989) and 
VLA-3  for collagen  and  fibronectin (Wayner and  Carter, 
1987; Takada et al.,  1988). The specificity of VLA-2 as a 
laminin receptor appeared to be determined by the cell type 
that expresses this molecule. Thus, on platelets VLA-2 func- 
tions as a specific collagen receptor (Kunicki et al.,  1988; 
Staatz et al.,  1989), whereas on endothelial cells and mela- 
noma cells the same molecule also can act as a laminin re- 
ceptor (Languino et al.,  1989; Elices and Hemler,  1989). 
The only VLA protein known at present that functions as a 
specific laminin receptor is VLA-6. 
The ix6 subunit of VLA-6 can also be found in a different 
heterodimeric complex, together with/~4 (Sonnenberg et al., 
1988b; Hemler et al.,  1989; Kajiji et al.,  1989). The ligand 
of the c~6/34 complex has not been identified. However, be- 
cause it shares the ct6 subunit with VLA-6, the possibility ex- 
ists that tx6B4 also functions as a laminin receptor. The a6B4 
complex can be demonstrated in epithelial cells of a variety 
of tissues and in Schwann cells (Sonnenberg et al.,  1989). 
Its expression in epithelial cells is restricted to the basal site 
of these cells, consistent with a matrix-adhesion function for 
ct6/54. 
A question of considerable interest is whether all of these 
receptors interact with the same or with distinct portions of 
the laminin molecule. To address this question, we have used 
well-characterized proteolytic fragments of laminin (Ott et 
al.,  1982;  Paulsson et al.,  1985; Deutzmann et al.,  1988; 
Mann et al.,  1988), determined the ability of various cells 
to bind to these fragments and examined the effects of mAbs 
against  integrin subunits  on this cell adhesion.  We found 
that, in addition to the major laminin cell-binding fragments 
P1 and E8, also E3 can support cell adhesion. Furthermore, 
we show that the VLA-6 (a6B1) complex mediates cell adhe- 
sion to E8, that the vitronectin receptor (otvB3) and addi- 
tional integrin B1 receptor(s) are involved in cell adhesion to 
P1 and that at least two receptors, one of which is a/~1 inte- 
grin, may be involved in cell attachment to E3. We were un- 
able to show that a6/34 can bind to laminin or its fragments. 
Materials and Methods 
Cell Adhesion Substrates and Synthetic Peptides 
Laminin (Timpl et al., 1979) and laminin-nidogan complex (Paulsson et al., 
1985) were purified from the mouse Englebreth-Holm-Swarm (EHS) I tu- 
mor as previously described. Laminin fragment P1 (Ott et al.,  1982) was 
obtained by digestion of the laminin-nidogen complex in 0.1 M glycine-HCI 
buffer, pH 1.9, for 24 h at 25°C with pepsin (enzyme-substrate ratio !:100) 
followed by chromatography on Sepharose CL-6B, at pH 7.2 (Mann et al., 
1988). A previously used less rigorous digestion procedure at pH 3 (Timpl 
et al., 1979) was found to yield fragment PI preparations that gave less con- 
sistent results in cell adhesion and RGD inhibition. Therefore only PI pre- 
pared at pH 1.9 was used in this study. Fragment E1X-Nd, which is similar 
to El-4, was obtained from an elastase digest of the same complex (Mann 
et al.,  1988),  but needed further chromatography on DEAE cellulose in 
2 M urea, 0.05 M Tris-HCI, pH 8.6 (Ott et al., 1982) to reduce its contami- 
nation by fragment E8 <1%. This further purification was shown to be es- 
sential for experiments with cell lines that require only low concentrations 
of fragment E8 for adhesion. Preparation of laminin fragments E3, E4, E8, 
and El0 has been previously described (Ott et al.,  1982;  Paulsson et al., 
1985; Mann et al., 1988).  Hexosamine analysis of El0 demonstrated four 
glucosamines showing that its single carbohydrate receptor site (Sasaki  et 
al.,  1987) is occupied by an N-linked oligosaccharide. 
All laminin fragments used were analyzed by fragment-specific radio- 
immunoinhibition assays (On et al.,  1982;  Paulsson et al.,  1985;  unpub- 
lished observations) to assess their purity.  Their contamination with other 
laminin structures was usually <1%. Fibronectin was purchased from Gib- 
co-BRL (Grand Island, NY). The synthetic peptide Cys-Asp-Pro-Gly-Tyr- 
lle-Gly-Ser-Arg-amide  (CDPGYIGSR), which corresponds to a cell attach- 
ment site in the B1 chain of laminin (Graf et al.,  1987),  and the synthetic 
peptide Gly-Arg-Gly-Asp-Ser-Pro  (GRGDSP) derived from the fibronectin 
cell attachment site (Pierschbacher and Ruoslahti, 1984), were prepared by 
solid-phase synthesis. We thank Dr.  S.  Henke (Hoechst AG, Frankfurt, 
FRG) for supplying the synthetic laminin peptide. 
Antibodies 
Antisera were raised in rabbits against purified laminin fragments E3, E4, 
and E8 as previously described (Ottet al.,  1982;  Paulsson et al.,  1985). 
These antisera showed comparable RIA titers for the fragment used for im- 
munization and an at least 10-20-fold lower binding capacity for the two 
unrelated fragments. The mouse mAb A-IA5 against the common/3 subunit 
of the integrin VLA protein family (Hemler et al., 1983),  the mouse mAb 
TS2/7 against t~l (Hemler et al., 1984) and the mouse mAb B-5GI0 against 
u4 subunit (Hemler et al., 1987) were kindly provided by Dr. M. E. Hemler 
(Dana Farber Cancer Institute, Boston, MA). A second mAh against the 
/31 subunit (AIIB2) was raised in a rat; it interferes with cell adhesion to 
fibronectin, laminin, and collagen (Werb et al., 1989).  The rat mAb BIE5 
recognizes the ct5 subunit and inhibits adhesion of cells to fibronectin (Werb 
et al., 1989). Both mAb AIIB2 and BIE5 were produced at the Department 
of Stomatology (University of San Francisco, San Francisco, CA). 
The rat mAb GoH3 was raised against the or6 subunit; it inhibits platelet 
adhesion to laminin (Sonnenberg et al.,  1987; Sonnenberg et al.,  1988a). 
Rabbit anti-or3 serum prepared against a synthetic peptide corresponding to 
the COOH-terminal 14-amino acid sequence derived from chicken cDNA 
clones (Hynes et al., 1989) was a gift of Dr. R. Hynes (Massachusetts Insti- 
tute of Technology,  Boston, MA). The mouse mAb 10Gl 1 directed against 
or2 (Giltay et al.,  1989) and the mouse mAb CI7 against 83 subunits (Tet- 
teroo et al.,  1983)  were produced at the Netherlands Red Cross Blood 
Transfusion Service (CLB),  Amsterdam,  The  Netherlands.  The  mouse 
mAb NKI-M9 directed against the w¢ subunit of the vitronectin receptor 
was kindly provided by Dr. C. Figdor (Netherlands Cancer Institute, Am- 
sterdam, The Netherlands). 
Cells and Cell Cultures 
Cell lines used included the human ovarian carcinoma OVCAR-4, the hu- 
man normal mammary HBL-100,  the human mammary tumor T47D,  and 
the human melanoma A375,  and the mouse mammary tumor cell lines 
1. Abbreviations  used in this paper:  EHS, Englebreth-Holm-Swarm tumor. 
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with 10%  (vol/vol) FCS. 
Cell Attachment and Inhibition Assays 
Microtiter plates (96-well, Greiner GmBH, Trickenhausen,  FRG) were coated 
with laminin or laminin fragments by incubating each well of the plate for 
12-16 h at 4°C with 100 txl of  protein solution diluted in PBS, pH 7.2. The 
wells were then washed with PBS and incubated with 150 #l of 1% (vol/vol) 
BSA in PBS for 60 rain to block remaining protein binding sites on the plas- 
tic. The efficiency of substrate coating was determined using 125I-labeled 
laminin or fragments (Aumailley et al.,  1989).  In the concentration range 
of  0.1-10/~g/ml,  9-10% of  the added laminin and 14-16% of  the P1 fragment 
were bound, whereas 14-17 % of  E3 was bound in the range of  0.1-50/zg/ml. 
Cells from subeonfluent, exponentially growing cultures were detached 
from the flask with 0.25%  (wt/vol) trypsin (Difco Laboratories, Surrey, 
UK), 0.02 % (wt/vol) EDTA and were suspended in 10 ml of DME contain- 
ing 10% (vol/vol) FCS. After centrifugation, the cells were washed twice 
with PBS and were finally resuspended in 150 mM NaCl at a concentration 
of 2-4  x  l07 cells/ml. The cells were radiolabeled with 51Cr as follows: 
0.4 ml of cell suspension was mixed with 0.4 ml (400 #Ci) of sodium 51Cr 
in 150 mM NaCI and 0.4 ml of  distilled water and incubated at room temper- 
ature for 30 min. The cells were then pelleted, washed twice with PBS and 
resuspended in DME containing 5 mg of  BSA per ml to a final concentration 
of 1-2  x  106 cells/ml. The specific activity of the labeled cells ranged 
from  1-2 cpm/cell. 
0.l-ml aliquots of  this cell suspension were added to individual substrate- 
coated wells and incubated for 30-40 min at 37°C. Nonadherent cells were 
removed by inverting the microtiter plates onto tissue paper and adsorption 
of  the medium. After the wells had been washed five times with DME-BSA, 
the bound radioactivity was determined by "~,-spectrometry. 
In the inhibition assays, cells were mixed with appropriate dilutions of 
antibodies or synthetic peptides, incubated for 60 min at room temperature 
and then plated onto coated wells for a 30-min attachment assay. 
Labeling and lmmunoprecipitations of Cell Surface 
Proteins 
Cells were surface-labeled with 1251 using the lactoperoxidase procedure, 
and then I% NP-40 cell lysates were used for immunoprecipitation as de- 
scribed (Sonnenberg et al., 1987; Sonnenberg et al., 198gb).  Immune com- 
plexes  were  collected  with  Protein  A-Sepharose (Pharmacia,  Uppsala, 
Sweden). Affinity-purified rabbit antiserum against mouse IgG and against 
rat lgG were included in immunoprecipitations, involving the mouse mAbs 
TS2/7,  10GI I, and B-5GI0 (IgGl antibodies) and the rat mAbs GoH3 and 
BIES,  respectively. The immunoprecipitates were analyzed on polyacryl- 
amide gels according to Laemmli (1970). 
Results 
Cell Adhesion to Laminin Fragments 
The  human  cell  lines  that  were  used  in  this  study  were 
selected because of their unique binding properties to differ- 
ent proteolytic fragments of laminin (for nomenclature and 
localization of the fragments,  see Fig.  1).  The proteolytic 
fragments were generated by digestion of mouse laminin of 
the EHS tumor with elastase or with pepsin.  Because the 
conditions of proteolysis may slightly vary in treating differ- 
ent samples of laminin,  we have tested various batches of 
these fragments. The cell adhesion activities of the E3 and 
E8  fragments  were  essentially  the  same  when  different 
batches of these fragments were used. For fragment P1, con- 
sistent results were obtained with material obtained by diges- 
tion at pH  1.9. 
OVCAR-4 cells showed good binding to the E8 fragment 
of laminin but adhesion to P1 has also been demonstrated 
in some experiments. T47D cells had a clear preference for 
binding to E3 and apparently did not or only weakly bind 
to  other  laminin  fragments  (Fig.  2).  The  adhesion  of 
OVCAR-4 cells to E8 and the adhesion of T47D cells to E3 
showed similar concentration dependence as the binding of 
these cells to  intact  laminin.  This  suggests  that  the cell- 
Nidogen:  150  kD 
El0:30  kD 
E4:75  kD 
P1  (darkened) : 200 kD,  cell 
attachment  activity 
EIX-Nd  (hatched and darkened) 
: >  300 kD 
E8  : 250-300  klAq, cell 
attachment  activity 
I 
ZOnm 
E3:50  kD,  cell attachment 
activity 
Figure  L  Schematic representation 
of the localization of laminin frag- 
ments in the cross-shaped mole- 
cule  based  on  previous  studies 
(Ott et ai.,  1982;  Paulsson et al., 
1985;  Mann et al.,  1988;  Deutz- 
mann et al.,  1988;  Sasaki  et al., 
1988). 
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Figure 2. Adhesion of cells to substrates coated with different concentrations of laminin and laminin fragments. A 96-well microtiter plate 
was coated with laminin (zx), E8 (o), PI  (A), and E3 (e) at the concentrations  indicated. Normal human mammary HBL-100, human 
mammary carcinoma T47D, human melanoma A375, and human ovarian carcinoma OVCAR-4 cells were labeled with 5tCr and allowed 
to attach at the coated wells as described in Materials and Methods. Total cells bound to wells coated with 50 #g of laminin per ml are 
indicated as  100%. The data are presented as the mean of triplicate determinations. 
binding sites on these two fragments and on intact laminin 
are very similar or even identical.  Important for the detec- 
tion of E3-mediated cell adhesion was the use of polystyrene 
microtiter plates coated with E3.  Tissue culture plates that 
have been used in previous studies gave variable results and 
were found to poorly bind cells. Cells of two other cell lines, 
HBL-100 and A375, showed binding to P1. The adhesion of 
these cells to P1 proved to be better than to intact laminin 
at lower concentrations of protein (Fig. 2). First,  when we 
consider the molar amounts, two to fourfold fewer P1  than 
laminin  molecules  were  required  to  support  adhesion  of 
A375-cells. This remains true after correction for the differ- 
ence in coating efficiency for these two molecules. Secondly, 
particularly with A375 ceils but also to a lesser extent with 
HBL-100 cells, the decline of adhesion at diminishing con- 
centrations was much less abrupt than in the case of laminin. 
The greater adhesion-promoting activity of the P1  frag- 
ment may indicate the presence of a binding site on P1 that 
is cryptic in the intact laminin molecule and requires proteo- 
lytic activation for its exposure. The existence of such a cryp- 
tic binding site was already suggested by Nurcombe et al. 
(1989).  In addition,  HBL-100, and to a lesser extent A375 
cells, bound to fragment E8 and showed variable adhesion 
between different experiments to fragment E3. This variabil- 
ity may be explained by a low affinity of adhesion, because 
relatively large amounts of E3 were needed to obtain bind- 
ing. In fact, for HBL-100 cells ~10 times as much adsorbed 
E3 protein was required as substrate to produce similar at- 
tachment as to laminin, which is 170-fold more on a molar 
basis. Laminin fragments E4, El0, and EIX-Nd were found 
to be inactive substrates for all four cell lines (not shown). 
Specificity of CeU Adhesion to Laminin and Laminin 
Fragments Examined by Antibody Inhibition 
The specificity of cell adhesion to the various laminin frag- 
ments was examined by antibody blocking experiments using 
polyclonal antisera against fragments E3, E4, or E8. Strong 
inhibition of cell adhesion was observed only by antibodies 
against the corresponding purified fragments (Table I). For 
example, binding of T47D cells to E3 could be blocked by 
antibodies against E3, but not by antibodies against E4 or E8. 
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to Laminin and to Laminin Fragments P1, E3,  and E8 
by Antilaminin Fragment Antisera 
Inhibition of cell adhesion byt 
Cell lines  Substrate*  Anti-E3  Anti-E4  Anti-E8 
% 
HBL- 100  Laminin  2  1  0 
P1  2  2  1 
E3  99  9  8 
E8  14  16  98 
T47D  Laminin  22  1  19 
E3  98  1  0 
OVCAR-4  Laminin  99  13  90 
E8  6  4  87 
A375  Laminin  68  9  69 
P1  7  17  19 
E3  99  10  11 
E8  8  7  99 
* Laminin and  laminin fragments  were prepared  at concentrations  that were 
shown in Fig.  1 to give plateau binding of cells. 
$ Cells  were  labeled with ~tCr and  incubated on the  coated  surfaces  in the 
presence  or absence of antiserum  against  laminin  fragments.  The  inhibitory 
effect of the antisera is presented as a mean of triplicate determinations and as 
the percentage of decrease in cell adhesion of that observed  in the absence of 
antibodies. The antisera were used at dilutions of 1:400 (HBL-100 and A375) 
and  1:200 (T47D and OVCAR-4). 
Similarly, binding of OVCAR-4 cells to E8 could be blocked 
by antibodies against E8, but not by antibodies to E3 or E4. 
It is also noteworthy that although adhesion of HBL-100 to 
E3  was variable,  this adhesion appeared to be specific as 
judged from the results of the blocking experiments.  None 
of the polyclonal antisera had a strong effect on cell adhesion 
to P1. 
When  the  same inhibition  experiments were performed 
with intact laminin or laminin-nidogen as substrates instead 
of its fragments, inhibition was less specific in that adhesion 
of OVCAR-4 cells to laminin, which occurs via E8, was also 
blocked by anti-E3 antibodies. We assume that this is due to 
steric hindrance of the binding site on E8 by antibodies fixed 
to E3, since these structures are close to each other in lami- 
nin (Deutzmann et al.,  1988).  Similar inhibition data have 
been reported for neurite  stimulation by laminin which  is 
mainly due to a fragment E8 structure (Edgar et al.,  1984). 
In contrast, some of the inhibition patterns observed with 
individual laminin fragments were not observed with intact 
laminin substrates. For example, the effect of the E3 antibod- 
ies on the adhesion of T47D cells to intact laminin was rela- 
tively weak when compared with the profound effect of the 
E3 antibodies on cell adhesion to the isolated E3 fragment. 
This may suggest that T47D cells also recognize another cell- 
binding site on laminin, distinct from the one on the E3 frag- 
ment. Alternatively, the epitopes on E3 that are involved in 
binding of the inhibitory antibodies may not be properly ex- 
posed on the intact laminin molecule. The same may also be 
true for HBL-100 cells, because adhesion to laminin cannot 
be blocked by either one or by the combination of E3- and 
E8-specific antibodies. 
Inhibition of Cell Adhesion by Synthetic Peptides 
Two synthetic peptides, GRGDSP (Pierschbacher and Ruos- 
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Figure 3.  Effect of synthetic peptide GRGDSP on the attachment 
of A375 and HBL-100 cells to P1. 5tCr-labeled HBL-100 (o) and 
A375 (e) cells were preincubated with or without GRGDSP peptide 
and added to the P1 substrates.  Total cells bound to P1 in the ab- 
sence of peptide are indicated as 100%. Data are presented as the 
mean of triplicate determinations. 
lahti,  1984)  and CDPGYIGSR-amide (Graf et al.,  1987), 
which were reported to interfere with cell attachment on var- 
ious extracellular substrates, were studied for their capacity 
to inhibit adhesion of cells to substrates made from the lami- 
nin-nidogen complex or the laminin fragments PI, E8, and 
E3. The only clear effect was observed with GRGDSP com- 
peting against a P1 substrate (Fig. 3). This was observed for 
both HBL-100 and A375 cells with 50 % inhibition requiring 
only low peptide concentrations ('~5 #g/ml). GRGDSP did 
not block cell attachment on laminin-nidogen,  E3, or E8, 
even when  used  at  30-40-fold  higher  concentrations  (not 
shown). Peptide CDPGYIGSR-amide, which corresponds to 
a laminin B1 chain sequence present in fragment P1, showed 
no or only marginal inhibition on all three substrates when 
examined in the concentration range  10-1,000 #g/ml. 
Inhibition of CeU Adhesion to Fragment P1 by Integrin 
{31 and {33 Antibodies 
The inhibition of cell adhesion to P1 by GRGDSP suggested 
that integrins were involved in this process. At least two inte- 
grins, the vitronectin and the fibronectin (VLA-5) receptor, 
are known to have ligand specificity for the RGD sequence 
in matrix proteins.  Therefore,  we examined whether anti- 
bodies against these two receptors interfered with cell adhe- 
sion to P1. 
As shown in Fig. 4, complete inhibition of cell adhesion 
to P1  was observed for HBL-100 cells with  mAb AIIB2, 
directed against the common/31 subunit of the VLA protein 
family and for A375 cells with a combination of mAb AIIB2 
(anti-b) and mAb C17 which recognizes the/~3  subunit of 
the vitronectin receptor. The individual antibodies did not 
(AIIB2) or only partially  (C17)  inhibit  adhesion of A375 
cells to P1. OVCAR-4 cells, which bind only weakly to P1, 
were sensitive to inhibition by mAb C17,  but not by mAb 
AIIB2 (not shown). 
The mAb BIE5, against the or5 subunit of the fibronectin 
receptor,  did  not  inhibit  on  cell  adhesion  to  P1.  In con- 
trast, BIE5 appeared to increase adhesion of A375 cells to 
P1.  The reason for this is unknown.  When BIE5 was com- 
bined with either C17 or AIIB2, also no inhibitory activity of 
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Figure 4. Inhibition of cell attachment to Pl by antibodies against 
integrin subunits. A 96-well microtiter plate was coated with l0 
/~g/ml P1.5~Cr-labeled HBL-100 (I) and A375 ([I) cells were pre- 
incubated with or without antibody and adhesion assays were per- 
formed as described in Materials and Methods. The antibodies 
were mAh Cl7, directed against/33, mAb AIIB, directed against/31, 
and mAb BIE5, directed against ctS. Total cells bound to PI in the 
absence of antibody are indicated as 100%. Adhesion was measured 
in triplicate, and the results from four separate sets of experiments 
were averaged. Error bars represent SEM of the averaged results 
from the four experiments. 
this antibody could be demonstrated. The BIE5 antibody, 
however, efficiently blocked adhesion of T47D and OVCAR-4 
cells to fibronectin (not shown). Adhesion of HBL-100 and 
A375 cells to fibronectin could not be prevented by BIE5 or 
by a combination of BIE5 and C17. 
From these results, we conclude that both/31 and/~3 inte- 
grin receptors can mediate cell adhesion to P1 and that the 
~l  receptor is not identical to the fibronectin receptor. 
Inhibition of CeU Adhesion to Fragment E8 by lntegrin 
~6 and 81 Antibodies and Variable Effect of lntegrin {Jl 
Antibodies on Cell Adhesion to Fragment E3 
We have recently shown that a rat mAb (GoH3) against the 
ct6 subunit of human VLA-6 blocked the interaction of plate- 
lets with laminin (Sonnenberg et al.,  1988a). To determine 
whether this antibody also interfered with adhesion of cells 
from the HBL-100, OVCAR-4, T47D, and A375 cell lines to 
laminin and  its cell-binding  fragments,  inhibition experi- 
ments were carried out.  As shown in Fig.  5, the antibody 
specifically blocked cell adhesion to E8. Adhesion to E3 or 
P1 (latter not shown) was not prevented by the mAb GoH3. 
Notably, the inhibitory activity of the a6-specific antibody 
for E8-mediated cell adhesion was observed for all cell lines 
that showed binding  to this fragment. When studied with 
laminin or laminin-nidogen substrates,  the antibody only 
blocked the adhesion of those cells which exclusively ad- 
hered to the E8 fragment of laminin, e.g., OVCAR-4 cells. 
The adhesion of HBL-100 and A375 cells, which recognize 
several cell-binding sites on laminin, was either not or only 
partially affected by the GoH3 antibody. Also, adhesion of 
T47D cells, which probably bind exclusively via the E3 cell- 
binding site to laminin was not affected by the mAb GoH3. 
Thus, it seems that GoH3 blocks cell adhesion to laminin 
only when the interaction of cells is mainly due to the E8- 
cell-binding site. 
The/31-specific antibody, mAb AIIB2, gives exactly the 
same results as GoH3 for the E8 cell-binding site. As GoH3 
and AIIB2 are directed against different parts of the t~6/~l 
complex, i.e., to the a6-chain and to the/31-chain, respec- 
tively, binding of cells to E8 is probably mediated by ct6/31 
and not by ct6/~4, which also occurs on these cells (see be- 
low). In addition, the/31-specific antibody blocked adhesion 
of A375 and HBL-100 cells to E3 for 56 and 72%, respec- 
tively, and completely prevented the adhesion of these cell 
lines as well as that of the OVCAR-4 cell line to intact lami- 
nin. Adhesion of T47D cells to either E3 or intact laminin 
was not affectexl by the AIIB2 antibody. These results suggest 
that there are two cell-binding sites present on the E3 frag- 
ment, one that is sensitive to inhibition by the/~l-specific an- 
tibody, AIIB2, and another one that is not. 
Analysis of ln  tegrin Receptors 
The antibody inhibition experiments clearly indicated that 
VLA-6 is an important mediator of cell binding to laminin. 
Other VLA proteins that have been shown to be capable of 
acting a laminin receptors are VLA-1 (Ignatius and Reichardt, 
1988), VLA-2 (Languino et al.,  1989; Elices and Hemler, 
1989), and VLA-3 (Wayner and Carter,  1987;  Gehlsen et 
al., 1988). To investigate the expression of these molecules and 
other integrin receptors and to relate this expression to the 
ability of cells to bind to the different laminin fragments, im- 
munoprecipitation experiments of surface-labeled compo- 
nents were carried out with subunit-specific antibodies. As 
shown in Fig. 6, both HBL-100 and OVCAR-4 cells, which 
bind well to the E8 fragment, clearly express VLA-6. Less 
VLA-6 was  detected on A375 cells,  which adhered more 
weakly to fragment E8, and almost no VLA-6 was found on 
T47D cells, which adhered poorly to this fragment. Thus, 
the level of VLA-6 expression is closely correlated with the 
ability of cells to adhere to fragment E8. 
No such correlation was found between c~6/~4 expression 
and adhesion of cells to ES.  For example, T47D cells ex- 
pressed high levels of ct6/~4, but poorly adhered to ES. This 
finding further supports the notion that ot6/~4 does not func- 
tion as a receptor for the E8 fragment. 
There are  also  marked differences in the expression of 
VLA-1 to VLA-5 proteins on the cells of the four cell lines. 
The HBL-100 and A375 cells express all five VLA proteins, 
whereas  T47D and  OVCAR-4  cells only express some of 
these molecules. In addition, the level of each of the VLA 
proteins varied on the cells of  the various cell lines. We found 
no  obvious  correlation  between  the  expression  of VLA 
subunits 1-5 and the ability of cells to bind to fragments E3, 
E8 or P1. 
Expression of the vitronectin receptor was examined by 
immunoprecipitation with antibodies against both ore and/~3 
subunits. Two cell lines, OVCAR-4 and A375, expressed the 
vitronectin receptor at high levels, whereas two other cell 
lines, T47D and HBL-100, showed significantly less expres- 
sion of this receptor (Fig. 7). The expression of the vitronec- 
tin receptor on A375 and OVCAR-4 cells is in good agree- 
ment with the effects of the/~3-specific antibody C17 on the 
adhesion of these cells to P1. We assume, however, that A375 
cells, in addition to the vitronectin receptor, express a sec- 
ond P1 receptor that belongs to the/~1 subfamily of integrins, 
since complete inhibition of A375 cell adhesion to P1  re- 
quires combination of C17 and AIIB2. 
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Figure 5. Inhibition of cell attachment to laminin, E3 and E8, by antibodies against integrin subunits. 5~Cr-labeled cells were preincubated 
with or without antibody and added to laminin, E8, and E3 substrates. The antibodies  were mAb GoH3, directed against c~6 (I) and mAb 
AIIB2, directed  against B1  ([]). Total cells bound to laminin in the absence of antibody (I) are indicated  as  100%.  Adhesion was mea- 
sured in triplicate, and the results from three separate sets of experiments were averaged. Error bars represent SEMs of the averaged results 
from the three experiments. 
Further Distinction between t~6~l and ct6134 lntegrin 
Involvement in Fragment E8 Adhesion 
In previous studies, we have shown that the mouse mammary 
tumor cell line RAC-11P expresses t~6/54, but not t~6/51 inte- 
grins (Sonnenberg et al.,  1988b; Sonnenberg et al.,  1989). 
A  spontaneous  transformant  of this  cell  line,  RAC-34E, 
however, was shown to express the ot6/~l complex in addition 
to t~6/~4.  Consistent with our above observations that only 
cells expressing a6/51 adhere to the E8 fragment of laminin, 
we found that RAC-34E but not RAC-11P  cells bind to ES. 
RAC-11P cells adhered well to laminin and its E3 fragment. 
In contrast, no binding to E3 was found of RAC-34E cells 
(Fig. 8). For reasons unknown, adhesion of RAC-34E cells 
to both laminin and E8 could only be partially inhibited by 
mAb GoH3. 
Discussion 
Adhesion of cells to laminin is a complex process involving 
many different attachment site~.  The results reported in this 
manuscript clearly establish  the presence  of at least three 
distinct cell-binding sites and correlate them, with some ex- 
ceptions,  to integrin receptor recognition. 
The E8 Cell-binding Site 
The E8 cell-binding site was recognized previously as an im- 
portant site for neurite outgrowth (Edgar et al.,  1984), myo- 
blast locomotion (Goodman et al., 1989), cell adhesion (Au- 
mailley et al., 1987; Goodman et al., 1987) and is apparently 
involved in maintaining cell  polarity (Klein et al.,  1988). 
Also, in our study several cell lines were found to adhere to 
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on HBL-100, T47D, A375 and OVCAR-4  cells. Ly- 
sates of ~25I-labeled HBL-100, T47D, A375, and 
OVCAR-4 cells  were  immunoprecipitated  with 
anti-cd (TS2/7), anti-c~2 (10Gll), anti-c~3 (cd pep- 
tide,  rabbit anti-serum),  anti-~4  (B-5G10), anti- 
a5 (BIE5), anti-c~6 (GoH3), anti-~l  (A-IA5), and 
control (normal rabbit serum). Samples were ana- 
lyzed  on  SDS-5%  polyacrylamide  gels  under 
reducing  and  nonreducing  conditions.  Notably, 
immunoprecipitation  of VLA-3, using  the  poly- 
clonal anti-c~3 peptide serum was very inefficient. 
Higher yields of VLA-3 were obtained when im- 
munoprecipitation  was carried  out with an mAb 
against cd (not shown). Analysis of VLA expres- 
sion by flow-cytometry confirmed the immunopre- 
cipitation  results and  showed that expression  of 
VLA-3 on HBL-100 and OVCAR-4 cells is five to 
six times higher than that of VLA-6 on these same 
cells. 
Figure 7. Analysis of  the vitronectin receptor from HBL-100, T47D, 
A375 and OVCAR-4 cells. Lysates of ~25I-labeled  HBL-100, T47D, 
A375, and  OVCAR-4 cells  were  immunoprecipitated  with  mAb 
NKI-M9 (lane I) and mAb C17 (lane 2), directed against the c~v 
and 83 subunits of the vitronectin receptor,  respectively. Samples 
were analyzed on a SDS-5 % polyacrylamide gel under nonreducing 
conditions. 
this site. The interaction of these cells with E8 could be in- 
hibited by mAb GoH3, directed against the a6 subunit of 
VLA-6, and by mAb AIIB2, directed against the common/31 
subunit of the VLA protein family. Moreover, we found that 
the expression of VLA-6 is closely correlated with the ability 
of ce!ls to adhere to the E8 fragment. These results strong- 
ly suggest that VLA-6 is an important mediator of cell bind- 
ing to E8. Three other VLA proteins, VLA-1, VLA-2, and 
VLA-3, have been implicated in cell adhesion to laminin. 
VLA-1 has been suggested to interact with the El-4 fragment 
oflaminin (Hall, D., L. Reichardt, and C. H. Damsky, unpub- 
lished results). Three of the cell lines used in this study ex- 
press the VLA-1 protein, but these cell lines did not bind to 
EIX-Nd; a  fragment similar to El-4.  Therefore, we cannot 
confirm that VLA-1 acts as a receptor for the El-4 fragment 
of laminin. The binding site for VLA-2 on the laminin mole- 
cule has so far not been mapped, but that for VLA-3 was 
shown to be located at or close to the terminal globule of the 
laminin long arm (Gehlsen et al.,  1989). VLA-3, therefore, 
in principle, can mediate binding of cells to the same frag- 
ment as VLA-6, i.e., E8. We have not examined the binding 
properties of cell lines that express the VLA-3 molecule as 
the only receptor for E8.  Only cell lines that express both 
VLA-3 and VLA-6 were investigated. Because adhesion of 
these latter cells could be completely blocked by the  c~6- 
specific mAb, GoH3, it is assumed that VLA-3 cannot play 
a  major role  in  cell adhesion  to E8,  when VLA-6 is also 
present. 
The P1 Cell-binding Site 
The P1  cell-binding site is a  cryptic cell-binding site,  not 
recognized by cells on the intact laminin molecule; that is 
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Figure 8. Effect of integrin or6 specific antibodies on the attachment 
of RAC-IIP and RAC-34E cells to laminin and to fragments of 
laminin. -~Cr-labeled cells were preincubated with or without an- 
tibody and added to laminin, E8, E3, and P1 substrates. Antibodies 
were mAb GoH3, directed against ~6 (m), and mAb JsE3, a con- 
trol rat antibody of the same isotype as GoH3 (~). Total cells bound 
to laminin in the absence of antibody (m) are indicated as 100%. 
Adhesion was measured in triplicate, and the results from four sepa- 
rate sets of experiments were averaged. Error bars represent SEMs 
of the averaged results from the four experiments. 
suggested by (a) the observed better adhesion of A375 and 
HBL-100 cells to P1  than  to  laminin,  (b)  the absence of 
adhesion-promoting activity of the larger E1X-Nd fragment, 
which comprises the P1 structure and (c) the fact that adhe- 
sion to P1, but not to laminin could be blocked by the syn- 
thetic Arg-Gly-Asp- (RGD) containing peptide. The proposed 
existence of  a cryptic P1 cell binding site is in agreement with 
observations made by Nurcombe et al. (1989). They showed 
that although the P1 fragment inhibited specific binding of 
'25I-labeled  iaminin  to  HT1080  cells,  this  inhibition  was 
noncompetitive. In contrast, inhibition of binding between 
fragment E8 and laminin was competitive. The P1 cell-bind- 
ing site can be exposed by proteolytic degradation either 
directly of the laminin-nidogen complex or via sequential 
proteolysis of the  E1X-Nd  fragment.  Because a  synthetic 
Arg-Gly-Asp- (RGD) containing peptide efficiently inhibited 
the attachment of cells to P1 and because an RGD sequence 
has been identified in one of the cysteine-rich domains of the 
A chain (Sasaki et al.,  1988), this sequence probably repre- 
sents the cell-binding site of PI. This has recently been con- 
firmed in biochemical studies (Aumailley et al., 1990). Wheth- 
er the P1 cell binding site is exposed and used in vivo is not 
known yet. The results of the antibody blocking experiments 
indicated that at least two cell surface receptors can mediate 
adhesion to P1. One of these is the vitronectin receptor, a 
promiscuous receptor that recognizes RGD sequences in a 
variety of adhesive glycoproteins (Cheresh,  1987;  Cheresh 
and Spiro,  1987; Charo et al.,  1987). The second receptor 
that mediates cell adhesion to P1 belongs to the/31 subfamily 
of integrins. The possibility has been considered that the/31 
receptor is identical to VLA-5; however, antibodies against 
or5, which could block interactions of cells to fibronectin, 
failed to inhibit cell binding to P1. Also, the fact that two cell 
lines, OVCAR-4 and T47D, showed good adhesion to fibro- 
nectin, but do not or only poorly adhere to P1, argues against 
a  possible  role of the  fibronectin receptor in cell binding 
to P1. 
In a recent study, the tenascin receptor has been shown to 
mediate RGD-dependent cell adhesion (Bourdon and Ruos- 
lahti,  1989). This receptor is a typical ctfll  integrin that is 
not related to any of the six known VLA proteins. It will be 
interesting  to  determine  whether  this  receptor facilitates 
binding of cells to P1. 
The E3 Cell-binding Site 
The recognition by cells of the E3 fragment of laminin was 
unexpected because in past studies this fragment was found 
not to promote cell adhesion or neurite stimulation (Edgar 
et al., 1984; Goodman et al., 1987). In our experience, cells 
adhere poorly to E3 coated on tissue culture plates, which 
were used in earlier studies. This is most probably due to a 
poorer coating of E3 to these plates at higher concentrations 
than to polystyrene plates (10 instead of 14%  of added E3 
is bound). The choice of  microtiter plate may be particularly 
important for detecting E3-mediated cell adhesion, because 
even if adequate polystyrene plates are used, relatively large 
amounts of this fragment are needed. At present, it is not 
clear which receptor(s) are involved in cell adhesion to E3. 
The finding that adhesion of HBL-100 and A375 cells to E3 
could be blocked by the anti-ill antibody, AIIB2, suggests 
that one of these receptors is a fll integrin. The T47D cells 
also adhere to E3, but the adhesion of these cells cannot be 
blocked by AUB2.  Therefore, T47D  cells  must  utilize a 
different receptor for binding  to E3.  The possibility that 
o~6fl4 functions as a receptor for E3 seems less likely be- 
cause HBL-100 cells express high levels of ot6fl4, but adhe- 
sion of these cells to E3 can be completely blocked by a ill- 
specific mAb, and RAC-34E cells also expressing high levels 
of oe6fl4, do not adhere to E3 at all. Because E3 contains a 
heparin-binding site (Ott et al., 1982), it appears more likely 
that proteoglycans can function as  receptor(s) for the E3 
binding site. In support of this, we have recently found that 
interaction of T47D cells with E3 could be prevented by low 
concentrations of heparin or dextran sulphate (Sonnenberg, 
A., and R. Timpl, unpublished observations). The best stud- 
ied proteoglycan is  syndecan, an integral membrane pro- 
teoglycan on epithelial cells which contains both heparan 
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1985).  Although this molecule mediates cell adhesion to a 
variety of extracellular matrix components, no binding was 
so far observed to laminin (Saunders and Bernfield, 1988). 
lnacave Cell-binding Fragments of  Laminin 
Fragment E1X-Nd corresponds to the previously described 
fragment E1-4/E1 (Paulsson et al.,  1985;  Goodman et al., 
1987).  When properly purified,  E1X-Nd  was  an  inactive 
adhesion substrate, even for rat Rugli cells, which have been 
found to adhere to E1-4/E1 (Goodman et al.,  1987).  We 
could show that a contamination by fragment E8 is responsi- 
ble for cell adhesion activity of less pure EIX-Nd prepara- 
tions, particularly with those cells that bind to low concen- 
trations of E8  by the  VLA-6 receptor.  Another inactive 
fragment, El0, corresponds to a globular domain in the short 
arm Bl-chain segment of laminin (Sasaki et al., 1987; Mann 
et al.,  1988).  A synthetic 14-mer peptide corresponding to 
an internal El0 sequence and possessing a potential N-gly- 
cosylation site (Sasaki et al., 1987) was shown to block hepa- 
rin and cell binding (Charonis et al.,  1988). 
The full occupation of the carbohydrate receptor site as 
shown here for fragment El0 could be responsible for its ina- 
bility to bind to cells and to heparin (Mann et al., 1988) and 
thus indicates a possible way to regulate the biological activ- 
ity of laminin by N-glycosylation. Fragment FA was also in- 
active in promoting cell adhesion confirming previous obser- 
vations (Goodman et al.,  1987).  It was recently shown to 
possess a major binding site for laminin self-assembly (Bruch 
et al., 1989), which may be the principal function of  the frag- 
ment E4 structure. 
The ~6{34 Complex Does Not Serve as a 
Receptor for E8 
Although the ligand of t~6/~4 has not been identified, we con- 
clude that it must be different from that of ot6/~l, the laminin 
E8 receptor. This conclusion is based on the following two 
findings: (a) human T47D and mouse RAC-11P ceils express 
ot6/$4 at high levels but do not adhere to E8, and (b) mAb 
AIIB2, directed against the common/~1 subunit, was capable 
of blocking adhesion of all human cells to E8,  including 
those  that  express  both  o~6/$4 and  t~6/~l.  Differences  in 
specificity of ligand binding due to the presence of a different 
subunit in the heterodimeric integrin has recently also been 
demonstrated for the vitronectin receptor (Cheresh et al., 
1989); the same receptor as the one identified in this report 
to bind to P1. The vitronectin receptor (ctv/~3) functions as 
a receptor for vitronectin, fibrinogen, and von Willebrand 
factor, whereas the novel vitronectin receptor (otv/3x) binds 
vitronectin and fibronectin, but not fibrinogen or yon Wil- 
lebrand factor. Another integrin ct subunit, which has been 
reported to form complexes with either of two #  subunits, 
is the mouse homologue of the or4 subunit of VLA-4 (Holz- 
mann and Weissman, 1989).  No difference in receptor spe- 
cificity was found for these two integrin forms of VLA-4. 
It is perhaps important to mention that the conclusion that 
a6~4 has a different ligand-binding specificity than a6~l 
does not imply that ~6/34 cannot interact with another do- 
main on laminin. Furthermore, there is the possibility that 
a6/~4 interacts with variant forms of  laminin. Recently, three 
variant forms, s-laminin (Hunter et al., 1989), heart laminin 
(Paulsson and Saladin,  1989),  and merosin (Ehrig et al., 
1990) have been described and it will be interesting to deter- 
mine whether either of these can bind to ot6B4. 
In conclusion, the approach used in this study has allowed 
the clear definition of three distinct cell-binding sites (E3, 
E8, and P1) on laminin and has given insight into the role of 
integrins in the recognition of these sites.  For the P1 frag- 
ment, RGD sequences were shown to be involved in receptor 
recognition of this structure;  it now will be important to 
identify the amino acid sequences within the E3 and E8 frag- 
ments that are recognized by the different adhesion receptors. 
We thank M. E. Hemler, R. Hynes, and C. Figdor for gifts of antibodies; 
S. Henke for the gift of peptide; C. P. Engelfriet for helpful comments on 
the manuscript; and W. Winkel for secretarial assistance. 
Received for publication 23 October 1989 and in revised form 15 January 
1990. 
References 
Aumailley, M., V. Nureombe, D. Edgar, M. Paulsson, and R. TimpL 1987. 
The cellular interactions of laminin fragments. J. Biol. Chem. 262: 11532- 
11538. 
Aumailley, M., K. Mann, K. von der Mark, and R. Timpl. 1989, Cell attach- 
ment properties of collagen type VI and Arg-Gly-Asp dependent binding to 
its a2(VI) and c~3(VI) chains. J.  Exp. CellRes.  181:463-474. 
Aumailley, M., M. Gerl, A. Sonnenberg, K. Deutzmann, and R. Timpl. Iden- 
tification  of the Arg-Gly-Asp sequence in laminin A chain as a latent cell 
binding site being exposed in fragment P1. FEBS (Fed. Fur. Biochem. Soc.) 
Lett. In press. 
Baron-van Evercooren, A., H.  K. Kleinman, S. Ohno, P.  Marangos, L  P. 
Schwartz, and M. E. Dubois-Dalcq. 1982. Nerve growth factor laminin and 
fibronectin promote neurite growth in human fetal sensory ganglia cultures. 
J.  Neurosci.  Res.  8:179-193. 
Bourdon, M. A., and E. Ruoslahti. 1989.  Tenascin mediates cell attachment 
through an RGD-dependent receptor. J.  Cell Biol. 108:1149-1155. 
Bruch, M., R. Landwehr, and I. Engel. 1989. Dissection of laminin by cathep- 
sin G into its long-arm and short-arm structures and localization  of regions 
involved in calcium-dependent stabilization and self-association. Fur. J. Bio- 
chem. In press. 
Charo, I. F., L. S. Bekeart, and D. R. Philips. 1987. Platelet glycoproteins Ilb- 
IIIa-like proteins mediate endothelial cell attachment  to adhesive proteins and 
the extracellular matrix. J.  Biol.  Chem. 262:9935-9938. 
Charonis, A. S., A. P. N. Skubitz, G. G. Koliakos, L. A. Reger, J.  Dege, 
A. M. Vogel, R. Wohlhueter, and L. T. Furcht. 1988.  A novel synthetic 
peptide from the B 1 chain of laminin with heparin-binding and cell adhesion- 
promoting activities.  J.  Cell Biol. 107:1253-1260. 
Cheresh, D. A. 1987. Human endothelial cells synthesize and express an Arg- 
Gly-Asp-directed adhesion receptor involved in atlachment to fibrinogen and 
yon Willebrand factor. Proc.  Natl. Acad.  Sci. USA. 84:6471-6475. 
Cheresh, D. A., and R. C. Spiro.  1987. Biosynthetic and functional properties 
of an Arg-Gly-Asp-directed receptor involved in human melanoma cell at- 
tachment to vitrone~tin,  fibdnogen and von Willebrand factor.  J,  Biol. 
Chem. 262:17703-17711. 
Cheresh, D. A., J. W. Smith, H. M. Cooper, and V. Quaranta. 1989. A novel 
vitronectin receptor integrin (av/3x) is responsible for distinct adhesive prop- 
erties of carcinoma cells. Celt. 57:59-69. 
Chung, A. E., R. Jaffe, I. L. Freeman, J. P. Vergnes, J. E. Braginski, and B. 
Carlin. 1979. Properties of a basement-membrane-related  glyeoprotein syn- 
thesized in culture by a mouse embryonal carcinoma-derived cell line. Cell. 
16:277-281. 
Deutzmann, R., J. Huber, K. A. Schmetz, I. Oberbiiumer, and L. Hartl.  1988. 
Structural studies of long-arm fragments of iaminin: evidence for repetitive 
C-terminal sequences in the A chain, not present in the B chain. Fur. J. Bio- 
chem.  177:35-45. 
Edgar, D., R. Timpl, and H. Thoenen. 1984. The heparin-binding domain of 
laminin is responsible for its effect on neurite outgrowth and neuronal sur- 
vival. EMBO  (Fur. Mol. Biol. Organ.) J.  3:1463-1468. 
Ehrig, K., I. Leivo, W. S. Argraves, E. Ruoslahti, and E. Engvall. 1990. The 
tissue specific basement membrane protein merosin is a laminin-like protein. 
Proc. Natl. Acad.  Sci. USA. In press. 
Elices, M. J., and M. E. Hemler. 1989. The human integrin VLA-2 is a colla- 
gen receptor on some ceils and a cotlagen/laminin receptor on others. Proc. 
Natl. Acad.  Sci. USA. 86:9906-9910. 
Gehlsen, K. R., L. DiUner,  E. Engvall, and E. Ruoslahti. 1988.  The human 
laminin receptor is a member of the integrin family of cell adhesion recep- 
tors. Science (Wash. DC). 241:1228-1229. 
Gehlsen, K. R., K. Dickerson, W. S. Argraves, E. Engvall, and E. Ruoslahi. 
The Journal of Cell Biology, Volume 110,  1990  2154 1989.  Subunit structure of iaminin-binding integrin and localization  of its 
binding site on laminin. J.  Biol. Chem. 264:4516-4519. 
Giltuy, J. C., H. J. M. Brinkman, P. W. Modderman, A. E. G. Kr. yon dem 
Borne, and J. A. van Mourik.  1989.  Human vascular endothelial cells ex- 
press a  membrane protein complex immunochemically indistinguishable 
from the platelet VLA-2 (glycoprotein la-IIa) complex. Blood. 73:1235- 
1241. 
Ginsberg, M. H., J. C. Loftus, and E. F. Plow. 1988. Cytoadhesins, integrins 
and platelets.  Thromb. Haemostasis.  59:1-6. 
Goodman, S. L., R. Deutzmarm, and K. yon der Mark. 1987. Two distinct cell- 
binding domains in laminin can independently promote nonneuronal cell 
adhesion and spreading. J.  Cell Biol. 105:589-598. 
Goodman, S. L., G. Risse, and K. yon der Mark. 1989.  The E8 subfragment 
of laminin promotes locomotion of myoblasts over extracellular matrix. J. 
Cell Biol. 109:799-809. 
Graf, J., R. C. Dyle, F. A. Robey, H. Sasaki, G. R. Martin, Y. Yamada, and 
H. K. Kleinman. 1987. A pentapeptide from the laminin El chain mediates 
cell  adhesion and  binds the 67000  lnminin receptor.  Biochemistry.  26: 
6896-6900. 
Hemler, M. E.  1988.  Adhesive protein receptors on hematopoietic cells, lm- 
munol.  Today. 9:109-113. 
Hemler, M. E., C. F. Ware, and J. L. Strominger. 1983. Characterization of 
a novel differentiation  antigen complex recognized by a monoclonal antibody 
(A-IA5): unique activation-specific molecular forms on stimulated T cells. 
J.  lmmanol.  131:334-340. 
Hemler,  M.  E.,  F.  Sanchez-Madrid,  T.  J.  Flotte,  A.  M.  Krensky,  S.  L 
Burakoff, A. K. Bhan, T. A. Springer, and J. L. Strominger. 1984. Glyco- 
proteins of 210 000 and 130 000 M. W. on activated T cells: cell distribution 
and antigenic relation to components on resting cells and T cell lines. J. lm- 
raunol.  132:3011-3018. 
Hemler, M. E., C. Huang, and L. Schwarz. 1987a.  The VLA protein family. 
J.  Biol. Chem. 262:3300-3309. 
Hemler, M.  E.,  C. Huang, Y. Takada, L.  Schwarz, J.  L.  Strominger, and 
M. L.  Clahby.  1987b.  Characterization  of the cell  surface heterodimer 
VLA-4 and related  peptides. J.  Biol. Chem. 262:11478-11485. 
Hemier, M.  E., C. Crouse, Y. Takada, and A. Sonnenberg.  1988.  Multiple 
very late antigen (VLA) heterodimers on platelets. J.  Biol.  Chem. 263: 
7660-7665. 
Hemier, M. E.,  C. Crouse, and  A. Sonnenberg. 1989.  Association  of  the  VLA 
o~6 suhunit  with a novel protein.  J. Biol. Chem.  264:6529-6535. 
Holzmann, B., and I. L. Weissman. 1989.  Peyer's  patch-specific  lymphocyte 
homing receptors  consists  of  a  VLA-4 like  ~ chain  associated  with  either  of 
two  integrin  B chains,  one  of  which  is  novel.  EMBO  (Eur. Mol. Biol. Organ.) 
J. 8:1735-1741. 
Hunter, D. D., V. Shah, J. P. Merlie,  and J. R. Sanes. 1989.  A laminin-like 
adhesive  protein  concentrated  in  the  synaptic  cleft  of  the  neuromuscular  junc- 
tion.  Nature (Lond.). 338:229-234. 
Hynes, R. O. 1987.  Integrins:  a family of cell  surface  receptors.  Cell. 48: 
549-554. 
Hynes, R. O., E. E, Marcantonio, M. A. Stepp,  L. A. Urry, and G. H. Ye~. 
1989.  Integrin  heterodimer  and  receptor  complexity  in  avian  and  mammalian 
cells.  J. Cell Biol. 109:409-420. 
Ignatius,  M. J.,  and  L. F. Reichardt.  1988.  Identification  of  a  neuronal  laminin 
receptor: an Mr 200k/120k integrin heterodimer that binds laminin in a diva- 
lent cation-dependent manner. Neuron.  1:713-725. 
Kajiji, S., R. N. Tamura, and V. Quaranta. 1989. A novel integrin (otEB4) from 
human epithelial cells suggests a fourth family of integrin adhesion recep- 
tors. EMBO (Eur. MoL  Biol. Organ.) J.  8:673-680. 
Klein, G., M. Langegger, R. Timpl, and P. Ekblom. 1988. Role of larninin A 
chain in the development of epithelial cell polarity.  Cell. 55:331-341. 
Kramer, R. H., and N. Marks. 1989. Identification  ofintegrin collagen recep- 
tors on human melanoma cells. J.  BioL  Chem. 264:4684--4688. 
Kramer, R. H., K. A. McDonald, and M. P. Vu. 1989. Human melanoma cells 
express a novel integrin receptor for laminin. J.  Biol. Chem. 264:15642- 
15649. 
Kunicki, T. J., D. J. Nugent, S. J. Staats, R. P. Orchekowski, E. A. Wayner, 
and W. G. Carter.  1988. The human fibroblast  class II extracellular matrix 
receptor mediate platelet adhesion to collagen and is identical  to the glyco- 
protein Ia-lla complex. J.  Biol. Chem. 263:4516-4519. 
Laemmli, U. K. 1970.  Cleavage of structural proteins during the assembly of 
the head of bacteriophage T4. Nature  (Land.). 227:680-685. 
Languino, L. R., K. R. G-ehlsen, E. Wayner, W. G. Carter, E. Engvall, and 
E. Ruoslahti. 1989. Endothelial cells use alpha-2/beta-1  integrin as a laminin 
receptor. J.  Cell Biol.  109:2455-2462. 
Mann, K., R. Deutzmann, and R. Timpl. 1988. Characterization of proteolytic 
fragments of the laminin-nidogen complex and their  activity  in ligand- 
binding  assays.  Fur. J. Biochem.  178:71-80. 
Martin,  G. R., and R. Timpl. 1987.  Laminin and other  basement membrane 
components. Annu. Rev. Cell. Biol. 3:57-85. 
Nurcombe, V.,  M. Aumailley,  R. Timpl,  and  D. Edgar. 1989.  The  high-aifinity 
binding  of  laminin  to  ceils.  Assignment of  a major cell  binding  site  to  the 
long arm of laminin and of a latent cell-binding site to its short arms. Eur. 
J.  Biochem.  180:9-14. 
Ott, U., E. Odermatt, J. Engel, H. Furthmayr, and R. Timpl. 1982. Protease 
resistance and conformation of laminin. Eur. J.  Biochem.  123:63-72. 
Paulsson, M., and K. Saladin.  1989.  Mouse heart laminin. Purification of the 
native protein and structural comparison with Engelbreth-Holm-Swarm tu- 
mor laminin. J.  Biol. Chem. 264:18726-18732. 
Paulsson, M., R. Deutzmann, R. Timpl, D. Dalzoppo, E. Odermatt, and J. En- 
gel. 1985. Evidence for coiled-coil  o~-helical  regions in the long arm of lami- 
nin. EMBO  (Fur. Mol. Biol. Organ.) J.  4:309-316. 
Paulsson, M., M. Aumallley, R. Deutzmann, R. Timpl, K. Beck, and J. Engel. 
1987.  Laminin-nidogen complex: extraction with chelating reagents and 
structural characterization. Fur. J.  Biochem.  166:11-19. 
Pierschbacher, M.  D.,  and E.  Ruoslahti.  1984.  Cell attachment activity at 
fibronectin can be duplicated by small synthetic fragments of the molecule. 
Nature  (Lond.). 309:30-33. 
Rapraeger, A., and M. Bernfield.  1985. Cell surface  proteoglycan of 
epithelial  ceils: protease release a heparan sulfate-rich ectndomain from a 
putative membrane-anchoring domain. J.  BioL Chem. 260:4103-4109. 
Ruoslahti, E., and M. Pierschbacher. 1987. New perspective in cell adhesion: 
RGD and integrins. Science  (Wash. DC).  238:491-497. 
Sasaki, M., S. Kato, K. Kohno, G. R. Martin, and Y. Yamada. 1987. Sequence 
of eDNA encoding the iaminin B1 chain reveals a multidomain protein con- 
raining cysteine-rich repeats. Proc. Natl. Acad.  Sci. USA. 984:935-939. 
Sasaki, M., H. K. Kleimnan, H. Huber, R. Deutzmann, and Y. Yamada. 1988. 
Laminin, a multidomain protein. J.  Biol. Chem. 263:16536-16544. 
Sannders, S., and M. Bernfield.  1988. Cell surface proteoglycan binds mouse 
mammary  epithelial cells to fibronectin and behaves as a receptor for intersti- 
tial matrix. J.  Cell Biol.  106:423-430. 
Sonnenberg, A., H. Janssen, F. Hogervorst, J. Calafat, and J. Hilgers. 1987. 
A complex of platelet glycoproteins Ic and Ha identified by a rat monoclonal 
antibody. J.  Biol. Chem. 262:10376-10383. 
Sonnenberg, A.,  P.  W.  Modderman, and  F.  Hogervorst.  1988a.  Laminin 
receptor on platelets is the integrin VLA-6. Nature  (Lond.). 336:487-489. 
Sonnenberg, A., F. Hogervorst, A. Osterop, and F. E. M. Veltman. 1988b. 
Identification  and characterization of a  novel antigen complex on mouse 
mammary  tumor cells using a monoclonal antibody against platelet glycopro- 
rein Ic. J.  Biol. Chem. 263:14030-14038. 
Sonnenberg, A., C. J. T. Linders, J. H. Daams, and S. J. Kennel. 1990. The 
c~6131 (VLA-6) and ce6134 protein complexes: tissue distribution and bio- 
chemical properties. J.  Cell Sci. In press. 
Springer, T. A., M. L. Dustin, T. K. Kishimoto, and S. D. Marlin. 1987. The 
lymphocyte function-associated LFA-1, CD2 and LFA-3 molecules: cell 
adhesion receptors of the immune system. Annu. Rev. Immunol. 5:223-252. 
Staatz, W. D., S. M. Rajpara, E. A. Wayner, W. G. Carter, and S. A. Santoro. 
1989.  The membrane glycoprotein Ia-IIa  (VLA-2) complex mediates the 
Mg2*-dependent  adhesion of platelets to collagen. J.  Cell Biol. 108:1917- 
1924. 
Takada, Y., E. A. Wayner, W. G. Carter, and M. E. Hemler. 1988. Extracellu- 
lar matrix receptors, ECMRII and ECMRI, for collagen and fibronectin cor- 
respond to VLA-2 and VLA-3 in the VLA-family of heterodimers. J.  Cell 
Biochem.  36:385-393. 
Tetteroo, P. A. T., P. M. Lansdorp, O. C. Leeksma, and A. E. G. Kr. von 
dem Borne.  1983. Monoclonal antibodies against human platelet glycopro- 
rein,  IHa.  Br. J.  Haematol.  55:509-522. 
Timpl, R., H. Rohde, P. G. Robey, S. I. Rennard, ff.-M. Foidart, and G. R. 
Martin. 1979. Laminin: a glycoprotein from basement membranes. J. Biol. 
Chem. 254:9933-9937. 
Timpl, R.  1989. Structure and biological activity of basement membrane pro- 
teins. Fur. J.  Biochem.  180:487-502. 
Turner, D. C., L. A. Flier, and S. Carbonetto.  1989.  Identification  of a cell- 
surface protein involved in PC 12 cell-substration adhesion and neurite out- 
growth on laminin and collagen. J.  Neurosci.  9:3287-3296. 
Wayner, E. A., and W. G. Carter. 1987. Identification of  multiple cell adhesion 
receptors for collagen and fibronectin in human fibrosarcoma cells possess- 
ing unique ot and common ~ subunits. J.  Cell Biol. 105:1873-1884. 
Werb, Z., P. M. Tremble, O. Behrendtsen, E. Crowley, and C. H. Damsky. 
1989.  Signal transduction through the  fibronectin receptor  induces col- 
lagenase and stromeysin gene expression. J.  Cell Biol. 109:877-889. 
Sonnenberg et al. Integrin Receptors for Different Domains on Laminin  2155 